IFP Exclusive

Iranian Companies Ready to Produce Favipiravir to Treat COVID-19

An infectious diseases specialist says Iranian companies have the ability and are ready to produce the Japanese drug Favipiravir, also known as Avigan, which is said to be effective in the treatment of COVID-19.

Dr Masoud Mardani, who is a member of National Committee for Coronavirus Fight, said if the results of clinical trials in the treatment of hospitalised patients are positive, Iranian companies can produce this drug on a large scale.

The price of the Iranian version of the drug will be much lower than foreign ones, and the patients with corona can easily use them, he said.

China has donated a limited number of Avigan to Iran, which has been given to researchers for further studies.

“Fortunately, the initial results of this research project were satisfactory, and we are waiting for the final result of the clinical trial of this drug.”

About three months ago, the Chinese used the drug to improve patients with COVID-19, and their studies have shown that it can be effective in treating the disease.

Favipiravir is an antiviral drug developed by the Japanese for influenza. About 2 years ago, it was discovered that it is also useful in treating Crimean Congo fever, stressed Mardani.

COVID-19 has no vaccine at the moment, he said. “There was no treatment approved by the US Food and Drug Administration, but last week, for the first time, the FDA approved a type of chloroquine for COVID-19.”

If you are worried that you may have contracted the Coronavirus, take this test right now.

Chloroquine is an anti-malarial drug, and has long been used to treat rheumatoid arthritis. By reducing inflammatory reactions, this drug can improve patients with the corona disease, underlined Mardani.

It has been earlier used in Iran and China, and has had good results in treating patients with mild to moderate corona disease.

“To cure COVID-19, there are some antiviral drugs including anti-AIDS medicine. We use this drug for coronavirus patients and they can improve the patients to some extent,” he concluded.

IFP Editorial Staff

The IFP Editorial Staff is composed of dozens of skilled journalists, news-writers, and analysts whose works are edited and published by experienced editors specialized in Iran News. The editor of each IFP Service is responsible for the report published by the Iran Front Page (IFP) news website, and can be contacted through the ways mentioned in the "IFP Editorial Staff" section.

Recent Posts

Iran does not rule out direct talks with US, advises Trump to avoid past mistakes

The Iranian government spokeswoman has not ruled out direct Iran-US talks under the new US…

42 mins ago

Over 320 humanitarian workers killed in Gaza since onset of war: UN

At least 322 humanitarian workers have been killed in the Gaza Strip since the war…

1 hour ago

Trump chooses Iran hawk as UN ambassador

US President-elect Donald Trump has nominated Republican Congresswoman Elise Stefanik, a staunch ally of Israel…

4 hours ago

Iran, Russia payment networks connected

Russia’s Mir payment network and Iran’s Shetab payment system were officially connected in a ceremony…

4 hours ago

Iran VP praises OIC-Arab League summit, calls for closer relations with Saudi Arabia

Iranian First Vice President Mohammad Reza Aref has stated that the joint summit meeting of…

4 hours ago

Iran executes man who raped 200 women

An Iranian man convicted of raping over 200 women was hanged on Tuesday in the…

5 hours ago